207 related articles for article (PubMed ID: 7878643)
21. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
22. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
[TBL] [Abstract][Full Text] [Related]
23. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
25. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
26. Isolation of a peptide antagonist to the thrombin receptor using phage display.
Doorbar J; Winter G
J Mol Biol; 1994 Dec; 244(4):361-9. PubMed ID: 7990127
[TBL] [Abstract][Full Text] [Related]
27. Development of potent thrombin receptor antagonist peptides.
Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
[TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
29. Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells.
Reilly CF; Connolly TM; Feng DM; Nutt RF; Mayer EJ
Biochem Biophys Res Commun; 1993 Feb; 190(3):1001-8. PubMed ID: 8382482
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of species differences in the platelet ADP and thrombin response.
Nylander S; Mattsson C; Lindahl TL
Thromb Res; 2006; 117(5):543-9. PubMed ID: 15921723
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA
Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.
Van Obberghen-Schilling E; Rasmussen UB; Vouret-Craviari V; Lentes KU; Pavirani A; Pouysségur J
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):667-71. PubMed ID: 7686363
[TBL] [Abstract][Full Text] [Related]
33. Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea-pigs in vivo.
Cicala C; Bucci M; De Dominicis G; Harriot P; Sorrentino L; Cirino G
Br J Pharmacol; 1999 Jan; 126(2):478-84. PubMed ID: 10077241
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.
Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Lee CY; Teng CM
Thromb Haemost; 2002 Jun; 87(6):1026-33. PubMed ID: 12083482
[TBL] [Abstract][Full Text] [Related]
35. Thrombostatin inhibits induced canine coronary thrombosis.
Hasan AA; Rebello SS; Smith E; Srikanth S; Werns S; Driscoll E; Faul J; Brenner D; Normolle D; Lucchesi BR; Schmaier AH
Thromb Haemost; 1999 Sep; 82(3):1182-7. PubMed ID: 10494785
[TBL] [Abstract][Full Text] [Related]
36. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides.
Vassallo RR; Kieber-Emmons T; Cichowski K; Brass LF
J Biol Chem; 1992 Mar; 267(9):6081-5. PubMed ID: 1313429
[TBL] [Abstract][Full Text] [Related]
37. Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation.
Coller BS; Springer KT; Scudder LE; Kutok JL; Ceruso M; Prestwich GD
J Biol Chem; 1993 Oct; 268(28):20741-3. PubMed ID: 8104935
[TBL] [Abstract][Full Text] [Related]
38. Solid tumor cells express functional "tethered ligand" thrombin receptor.
Wojtukiewicz MZ; Tang DG; Ben-Josef E; Renaud C; Walz DA; Honn KV
Cancer Res; 1995 Feb; 55(3):698-704. PubMed ID: 7834643
[TBL] [Abstract][Full Text] [Related]
39. Indications for the presence of an atypical protease-activated receptor on rat platelets.
Ruef J; Kacharava A; Pohl J; Bode C; Runge MS
Ann Hematol; 2000 Nov; 79(11):604-11. PubMed ID: 11131919
[TBL] [Abstract][Full Text] [Related]
40. Protease-activated receptor 1 antagonists prevent platelet aggregation and adhesion without affecting thrombin time.
Nadal-Wollbold F; Bocquet A; Bourbon T; Létienne R; Le Grand B
Eur J Pharmacol; 2010 Oct; 644(1-3):188-94. PubMed ID: 20655904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
